Anthropic has formally opened its Milan office, naming Generali, Unipol, Pirelli, Enel and others as Italian enterprise customers and explicitly linking the launch to Pope Leo’s AI encyclical.
Morgan Stanley has doubled its forecast for AI-driven European banking job losses to 20% of the workforce by 2030, with cuts already underway at UBS, ABN Amro, HSBC and Société Générale.
Meta’s push into AI subscriptions and OpenAI/xAI’s push into advertising define the next phase of the consumer-AI revenue-model debate. None of the three is comfortable with the convergence.
Emarketer projects Meta's ad revenue will reach $243.5B in 2026, surpassing Google's $239.5B for the first time. Advantage+ AI automation is driving the shift.
The Pentagon has awarded Dell a five-year, $9.7bn contract to consolidate Microsoft software licensing across the US military and intelligence agencies, projected to save $422m a year.
AtlasEdge, the Liberty Global / DigitalBridge joint venture, has secured $1.2bn in debt financing to scale its European data-centre footprint, the largest single facility in its history.
Orbital Industries, formerly Orbital Materials, has raised a $50M Series B led by Plural with Nvidia’s NVentures, for AI-designed PFAS-free GPU cooling fluid and modular data-centre infrastructure.
The European Commission has fined Temu €200M under the Digital Services Act for failing to prevent the sale of unsafe baby toys and faulty chargers, the regime’s second major enforcement action.
Mistral CEO Arthur Mensch pushed back directly against Pope Leo XIV’s call to disarm AI, arguing Europe cannot afford unilateral restraint while adversaries deploy the technology.
Snowflake has committed $6bn to AWS over five years, 2.4x larger than its 2023 deal, with AWS Graviton chips at the centre. Shares jumped 38% on the news and a Q1 earnings beat.
Wix lays off 1,000 employees, 20% of staff, as a strong shekel and AI competition squeeze the website builder. Stock has fallen 50% in 2026 after an earnings miss.
Healthcare executive Donna R. Cryer argues that AI systems are being deployed across hospitals and pharma without patient governance, and that a Chief Patient Officer role is overdue.